The efficacy of lobaplatin combined with docetaxel versus docetaxel alone as the second-line treatment for advanced non-small cell lung cancer

HE An-bing; LUO Yun-xiu; WANG Qun; TONG Wen-xian; LIU Ai-hua

doi:10.3969/j.issn.1009-0460.2012.10.014

Home>Articles>The efficacy of lobaplatin combined with docetaxel versus docetaxel alone as the second-line treatment for advanced non-small cell lung cancer

DOI: 10.3969/j.issn.1009-0460.2012.10.014

The efficacy of lobaplatin combined with docetaxel versus docetaxel alone as the second-line treatment for advanced non-small cell lung cancer

HE An-bing

LUO Yun-xiu

WANG Qun

TONG Wen-xian

LIU Ai-hua

Machine-generated Keywords：

Publication Date：2012-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 923-926 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2012,17(10)